As of 18 Sept 2026, Morepen Laboratories Ltd share price is ₹121.40. The stock opened at ₹121.40 and had closed at ₹120.65 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹33.44 and a high of ₹122.45. In terms of performance, Morepen Laboratories Ltd share price has increased by 225.55% over the past six months and has increased by 122.81% over the last year.
MOREPENLAB Stock Price Chart
Morepen Laboratories Ltd Overview
About MOREPENLAB
Morepen Laboratories engaged with the medical fraternity and the wider public on matters of everyday health. Leveraging the leadership position of Saltum, the No. 1 brand in its category in the Indian pharmaceutical market, the Company conducted a dedicated campaign during Antimicrobial Resistance (AMR) Awareness Week to reinforce responsible antibiotic use among physicians and patients.
Morepen Laboratories Ltd Historical Performance
Morepen Laboratories Ltd Fundamentals
Morepen Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1,702.70 | 1,570.26 | 1,550.16 | 1,344.64 | 1,459.51 |
| EBITDA | 134.67 | 169.13 | 174.39 | 83.03 | 139.36 |
| Net Profit | 66.06 | 101.58 | 110.94 | 46.24 | 101.06 |
| EPS | 1.21 | 1.90 | 2.17 | 0.92 | 2.25 |
Morepen Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 115.13 |
| Resistance 1 (R1) | 123.73 |
| Pivot Point | 118.22 |
Morepen Laboratories Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 18-Sep-2026 | 26-May-2026 | 19-Sep-2026 | Final | ₹0.20 |
| 29-Aug-2025 | 12-May-2025 | 30-Aug-2025 | Final | ₹0.20 |
MOREPENLAB Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Sushil Suri | Chairman |
| Sanjay Suri | WTD & Executive Directorector |
| Praveen Kumar Dutt | Non Executive Independent Director |
Morepen Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,853.00-0.77% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,371.50+0.52% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,865.50-0.19% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Morepen Laboratories Ltd today is ₹121.40 on NSE and ₹121.40 on BSE.
- The 52-week high of Morepen Laboratories Ltd is ₹122.45, while the 52-week low is ₹33.44.
- The current market capitalisation of Morepen Laboratories Ltd is approximately ₹6,611 crore.
- The P/E (Price-to-Earnings) ratio of Morepen Laboratories Ltd is 22.27. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Morepen Laboratories Ltd is 1.87. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Morepen Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for MOREPENLAB on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Morepen Laboratories Ltd has delivered a return of approximately 223.55%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Morepen Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 35.65% promoters, 1.46% FIIs, 1.28% DIIs, and 49.75% public shareholders.

